New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 6, 2012
17:40 EDTAPRIApricus Biosciences CEO Bassam Damaj resigns, CFO Steve Martin named interim CEO
Apricus Biosciences announced that Bassam Damaj, Ph.D., has resigned as a director, president, and CEO of the company and that Steve Martin, senior vice president and CFO, has been appointed interim CEO. The changes are effective immediately. The company also announced that its board has retained an executive recruiting firm to assist in identifying a permanent CEO whose experience is expected to include significant background in commercial operations within the pharmaceutical industry.
News For APRI From The Last 14 Days
Check below for free stories on APRI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 16, 2014
12:00 EDTAPRIApricus Biosciences rises 17.5%
Subscribe for More Information
10:34 EDTAPRIApricus Biosciences reports Takeda accepts first shipment of Vitaros
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use